Initially, the rash vanished swiftly but soon returned, spreading further, leading to prescriptions of even stronger steroids ...

A woman says a steroid cream left her in pain so severe, she now wants to raise awareness of the condition behind it.

Nektar Therapeutics (NASDAQ: NKTR) stock exploded nearly 157% following news that Rezpeg, the company’s experimental ...

A woman who had a small rash now looks 'like a burns victim' - after she suffered an extreme reaction to a common cream.

A woman who had a small rash now looks 'like a burns victim' - after she suffered an extreme reaction to a common cream.

Francesca Tebbutt, 33, from Clunderwen in Wales, spent years unaware of what was causing the condition that left her feeling ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Nektar Therapeutics (NKTR) stock jumps as the company's lead drug rezpegaldesleukin meets primary & secondary goals in a Phase 2b eczema trial. Read more here.

Patch testing serves as a diagnostic method to identify whether specific ingredients in skincare products cause adverse ...

"I looked like a burn victim... even my nephews and nieces were scared of me - they looked at me like I was something out of ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...